Dr. Caitlin L. Costello, MD

Dr. Costello practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Costello's NPI, 1760649230, was assigned on May 21, 2008. Dr. Costello graduated from Tufts University School Of Medicine in 2006. Dr. Costello holds California license A108322.

Dr. Costello's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Costello's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Costello is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Costello to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Costello practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Costello's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Costello is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Costello's licenses on file in 2 states: California and New York.

Dmand AI lists arterial blot clot /embolism, chronic anemia, chronic leukemia, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Costello treats.

CMS data shows 1,411 Medicare services from Dr. Costello across 8 procedure codes in 2024, for 276 Medicare patients. Medicare paid $100,931 for them.

CMS counts 276 Medicare patients who saw Dr. Costello in 2024. The largest group is 65 to 74, with 143 patients. 66% of them have high cholesterol, and 64% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Costello's median patient age at 69, with 48% women.

In 2024, Dr. Costello wrote 1,233 Medicare Part D claims for 138 patients. 65% of them were for generic drugs. CMS names the drug for 1,021 of them, across 29 drugs with 11 or more claims each, at $7,444,111 in total drug cost. In 2023, CMS named 809 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Costello for performance year 2024, reported as part of a group. Dr. Costello accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Costello as offering telehealth.

Dmand AI links 49 papers to Dr. Costello, published from 2011 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Dexamethasone. Dr. Costello has published most often in Future Oncol. Dr. Costello's most frequent co-authors are Saad Z. Usmani, MD, Ajai Chari, MD and Andrzej J. Jakubowiak.

Dmand AI links Dr. Costello to 9 clinical trials, 2 of them phase 1 studies. 6 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Leukemia, Myelogenous, Chronic, BCR-ABL Positive.

CMS Open Payments shows 179 general payments to Dr. Costello from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Millennium Pharmaceuticals, Inc. paid the most, $56,665. It also lists 19 research payments totaling $31,272 from 2020 to 2023.

Dmand AI lists 5 awards for Dr. Costello, most recently Abstract Achievement Award in 2011.

Dr. Costello graduated from Tufts University School Of Medicine in 2006.

Dr. Costello is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.